China Pharma Holdings (CPHI) Financials

$0.78

$0.02 (2.50%)

As on 09-Sep-2026 16:25EDT

Market cap

$36 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	3.91	4.14	4.53	7.01	8.10	9.64
Cost of Revenue	4.28	4.28	6.51	7.29	8.60	9.29
Gross Profit	-0.37	-0.13	-1.99	-0.28	-0.49	0.35
Operating Expenses	5.09	2.96	2.60	2.47	3.06	3.21
Operating Profit (EBIT)	-4.38	-3.09	-4.59	-2.75	-3.55	-2.86
Other Income	--	--	--	--	--	--
Profit before Tax	-4.47	-3.19	-4.74	-3.08	-3.97	-3.40
Provision for Tax	--	--	-4,736,360.26	0.00	6.25	0.54
Profit after Tax (Net Income)	-4.47	-3.19	-4.74	-3.08	-3.97	-3.40
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-3.40

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	36.18	22.74	7.75	7.45	4.29	6.02
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.85	0.86	2.12	2.19	0.75	6.12
Current Liabilities	7.68	7.40	5.02	6.82	12.74	10.51
Total Liabilities	52.39	31.00	14.89	16.47	17.78	22.65

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	42.70	28.65	11.62	10.47	11.82	13.56
Current Assets	2.01	2.35	3.27	6.00	5.96	9.09
Total Assets	46.72	31.00	14.89	16.47	17.78	22.65
Total Debt*	3.75	3.89	3.59	4.63	8.76	12.49
Net Current Assets	--	-5.05	-1.75	-0.82	-6.77	-1.42

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	0.15	-0.47	-0.70	-0.41	-0.25
Cash Flow from Investing Activities	--	-0.14	-0.29	-0.01	-0.40	-0.44
Cash from Financing Activities	--	-0.29	0.03	0.07	-1.77	4.60
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.85	-0.21	-1.00	-0.29	-0.62	-0.71
Cash EPS ($)	--	-0.10	-0.45	-0.04	-0.20	-0.07
Adjusted Book Value ($)	--	1.47	1.63	0.70	0.67	1.26
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.01	-0.10	-0.07	-0.06	-0.05
Free Cash Flow per Share ($)	--	0.00	-0.16	-0.07	-0.13	-0.14

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-16.79	-40.43	-24.50	-25.18	-20.03
ROE (%)	-15.19	-20.91	-62.31	-52.43	-77.08	-48.49
ROA (%)	-13.62	-13.89	-30.21	-17.98	-19.65	-15.53
EBIT Margin (%)	-81.15	-74.45	-101.18	-39.15	-43.66	-29.64
Net Margin (%)	-114.33	-76.91	-104.58	-43.91	-49.02	-35.26
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-10.97	-0.08	-0.35	-0.13	-0.16	-0.11
EBIT Growth (%)	-14.28	32.66	-66.92	22.41	-23.82	-11.07
Net Profit Growth (%)	-22.39	32.70	-53.84	22.50	-16.87	-18.58
EPS Growth (%)	-1.72	0.79	-2.44	0.53	0.13	-0.14
Book Value Growth (%)	325.66	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.89	-0.23	-0.41	-0.16	-0.68
Price / Book Value	1.05	0.83	0.14	0.17	0.14	0.38
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-225.89	-14.82	319,156.60	523.87	-8.75	42.73
Close Price ($)	--	1.21	2.33	6.00	47.95	241.30
High Price ($)	--	3.35	6.20	60.60	263.00	815.00
Low Price ($)	--	1.18	1.30	4.00	45.15	200.50
Market Cap ($ Cr)	36.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.17	0.46	0.62	2.04	2.08
Short term debt to equity ratio	0.10	0.17	0.28	0.43	2.04	1.20
Current Ratio	0.26	0.32	0.65	0.88	0.47	0.86
Quick Ratio	0.08	0.10	0.20	0.33	0.24	0.55
Interest Coverage	-44.18	-30.24	-29.73	-8.23	-8.14	-5.27

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	6.34	7.01	6.21	10.39	5.73	8.66
Asset Turnover	0.12	0.18	0.29	0.41	0.40	0.44
Receivable days	--	25.19	40.70	31.07	29.29	25.85
Inventory Days	--	166.03	168.16	167.30	133.55	138.45
Payable days	--	47.67	33.40	40.91	33.85	42.48
Cash Conversion Cycle	--	143.55	175.46	157.46	128.99	121.83

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.